Aetion, the software platform company, announced that Brigham and Women’s Hospital (BWH) and Harvard Medical School (HMS) chose the Aetion Evidence Platform to support their work on the REPEAT program.
The REPEAT program-Reproducible Evidence: Practices to Enhance and Achieve Transparency-focuses on quantifying the current state of transparency in health care database studies and developing guidance so that decision-makers are able to evaluate evidence from real-world data and drive better health care decisions. The platform distributes real-world analytics and evidence needed for biopharma and payers to engage in value-based care.
Can Data and AI Deliver Whole-Person Health?
July 9th 2024Executives in the life sciences and medical device industries see promise in artificial intelligence (AI) and medical technologies, but must also navigate the changing healthcare ecosystem, varied stakeholder needs, and the impact of AI on market access and commercialization strategies.